Evidence map›Paper›PMID 28438998›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

Cas1 and the Csy complex are opposing regulators of Cas2/3 nuclease activity.

MaryClare F Rollins, Saikat Chowdhury, Joshua Carter, Sarah M Golden, Royce A Wilkinson, Joseph Bondy-Denomy, Gabriel C Lander, Blake Wiedenheft

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 96 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Mechanistic insights into DNA binding and cleavage by a compact type I-F CRISPR-Cas system in bacteriophage.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Frontiers in microbiology · 2022
    Article
  19. Review
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

MaryClare F RollinsDepartment of Microbiology and Immunology, Montana State University, Bozeman, MT 59717.
Saikat ChowdhuryDepartment of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037.
Joshua CarterDepartment of Microbiology and Immunology, Montana State University, Bozeman, MT 59717.
Sarah M GoldenDepartment of Microbiology and Immunology, Montana State University, Bozeman, MT 59717.
Royce A WilkinsonDepartment of Microbiology and Immunology, Montana State University, Bozeman, MT 59717.
Joseph Bondy-DenomyDepartment of Microbiology and Immunology, University of California, San Francisco, CA 94158.
Gabriel C LanderDepartment of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037.
Blake WiedenheftDepartment of Microbiology and Immunology, Montana State University, Bozeman, MT 59717; bwiedenheft@gmail.com.
Montana State University · USScripps Research Institute · USUniversity of California, San Francisco · US

Funding

Pilot Grants ProgramP30GM110732 · NIGMS · MONTANA STATE UNIVERSITY - BOZEMAN · PI SCHMIDT, EDWARD E · 2014 to 2018
$5.4M
Center for Zoonotic and Emerging Infectious DiseasesP20GM103500 · NIGMS · MONTANA STATE UNIVERSITY - BOZEMAN · PI QUINN, MARK T · 2012 to 2013
$4.2M
Molecular basis of axonal transport described by high-resolution 3D imagingDP2EB020402 · NIBIB · SCRIPPS RESEARCH INSTITUTE, THE · PI LANDER, GABRIEL C · 2014 to 2014
$2.8M
Discovering New Roles for CRISPR-Cas in Bacterial PathogenesisDP5OD021344 · OD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BONDY-DENOMY, JOSEPH · 2015 to 2019
$2.1M
Structure, Function and Application of CRISPR RNA-guided Immunity in BacteriaR01GM108888 · NIGMS · MONTANA STATE UNIVERSITY - BOZEMAN · PI WIEDENHEFT, BLAKE A · 2014 to 2019
$1.6M
Structure and function of CRISPR RNA-guided foreign DNA surveillance systems in P. aeruginosaR01GM110270 · NIGMS · MONTANA STATE UNIVERSITY - BOZEMAN · PI WIEDENHEFT, BLAKE A · 2016 to 2019
$1.2M
NIBIB NIH HHS DP2 EB020402NIGMS NIH HHS P20 GM103500NIGMS NIH HHS P30 GM110732NIGMS NIH HHS R01 GM108888NIGMS NIH HHS R01 GM110270NIH HHS DP5 OD021344
6 · The paper itself

Abstract

The type I-F CRISPR adaptive immune system in

Indexed as

Bacterial ProteinsCRISPR-Cas SystemsDeoxyribonucleasesMultienzyme ComplexesPseudomonas aeruginosaBacterial ProteinsDeoxyribonucleasesMultienzyme ComplexesCasCas1Cas2/3CRISPRtype I-F

Identifiers

PMID28438998
PMCPMC5495223
OpenAlexW2608395333

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.